Brief: Mithra Pharmaceuticals Issues Put Option Notice Under Capital Agreement With LDA Capital
Nov 17 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* MITHRA ISSUES A PUT OPTION NOTICE UNDER CAPITAL AGREEMENT
WITH
LDA CAPITAL
* UNDER TERMS OF THIS AGREEMENT EXTENDED IN APRIL 2022, LDA
CAPITAL COMMITS AN AMOUNT OF UP TO EUR 75 MILLION IN CASH WITHIN
A MAXIMUM OF FIVE YEARS (UNTIL APRIL 2025) IN EXCHANGE FOR NEW
ORDINARY SHARES IN MITHRA.
* THIS IS FIFTH PUT OPTION NOTICE RELATED TO THIS AGREEMENT
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO